Rapamycin vs Longevity Supplements for Cats and Dogs: What Has Real Evidence

The pet longevity shelf is crowded — NAD boosters, spermidine, senolytics, omega-3s — and most of it is sold with more confidence than the evidence supports. Rapamycin sits apart because it is a prescription medicine with decades of study, not a supplement. This comparison is honest about where each one genuinely fits, including where supplements are the better choice.

The short version

| | Longevity supplements | Rapamycin | |---|---|---| | Evidence depth | Mostly early or extrapolated from other species | 50+ years of study; extends healthy lifespan in lab mammals; in canine and feline trials now | | Prescription needed | No | Yes — veterinarian-directed | | Cost | Low (often €10–€40/month) | Higher (~€100+/month, review included) | | Best for | General support, easy to start, low risk | A considered, monitored longevity or cardiac protocol | | Main risk | Wasted money on unproven products | Not for every animal; needs a vet |

Where supplements genuinely win

This is not a straw man — supplements have real advantages, and for many owners they are the right starting point:

• No prescription, no gatekeeping. You can start today, without a vet review.
• Cheap and low-risk. A quality omega-3 (EPA/DHA) has good evidence for joint and cognitive support and costs very little. That is a sensible buy on its own terms.
• No dosing complexity. Nothing to calibrate to body weight, nothing to monitor.

If you want something simple, affordable and safe to begin with, a well-chosen supplement is a reasonable choice, and nobody should talk you out of it.

Where rapamycin’s evidence is deeper

What rapamycin has that the supplement shelf mostly does not is depth of study on the aging process itself. It targets mTOR, a central pathway in how cells age, and it is the intervention that most reliably extended healthy lifespan across laboratory-mammal studies. It is now in companion-animal trials — the NIH-funded TRIAD trial in dogs, and placebo-controlled work in feline heart disease. Those trials have not delivered final answers, so the honest framing for cats and dogs is under investigation — but it is being investigated at a level no popular supplement can match.

The trade-off is real: rapamycin needs a prescription, costs more, and is not right for every animal. You are paying for a studied molecule and veterinary oversight, not a tub off a shelf.

How to choose

• Just getting started, want simple and cheap: a quality omega-3, and talk to your vet about the rest.
• Have an older animal and want a considered, monitored protocol: rapamycin is worth discussing with a veterinarian.
• Have a cat diagnosed with HCM: this is the setting where rapamycin is under the most active study — read our HCM piece and speak to your cardiologist.
• Want the underlying research before deciding anything: read it yourself.

For the research laid out study by study, with nothing to sell you, see the evidence library at Our Beloved Friends.

If a veterinarian-directed protocol is what you are weighing, Rapavie’s therapy for cats and dogs begins with a review — and if your animal is not a candidate, it is declined and refunded.